Social Aspects Of Drug Discovery, Development And Commercialization

Paperback | February 12, 2016

byOdilia Osakwe, Syed A.a. Rizvi

not yet rated|write a review
Social Aspects of Drug Discovery, Development and Commercialization provides an insightful analysis of the drug discovery and development landscape as it relates to society. This book examines the scientific, legal, philosophical, economic, political, ethical and cultural factors that contribute to drug development. The pharmaceutical industry is under scrutiny to develop safer and more effective drugs in a quicker and more affordable manner. Recent criticism and debates have emphasized varying opinions on the issues concerning the drug discovery and development process. This book provides thoughtful and valuable discussions and analysis of the social challenges and potential opportunities through all stages of the pharmaceutical process, from inception through marketing. With a unique focus on the social factors that increasingly play a role in how drug development is planned, structured, and executed throughout the drug product lifecycle, this is an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society. Organized in a sequence of interrelated theories and principles that provide the foundation for increased understanding of the relevant social aspects Includes analysis of important new advances, key scientific and strategic issues, and overviews of recent progress in drug development Provides a global perspective with examples from developed areas, such as the US, Japan, Canada and Europe, as well as faster-growing and emerging economies including Brazil, Russia, India, and China Serves as an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society

Pricing and Purchase Info

$116.11 online
$128.95 list price (save 9%)
In stock online
Ships free on orders over $25

From the Publisher

Social Aspects of Drug Discovery, Development and Commercialization provides an insightful analysis of the drug discovery and development landscape as it relates to society. This book examines the scientific, legal, philosophical, economic, political, ethical and cultural factors that contribute to drug development. The pharmaceutical ...

Dr. Odilia Osakwe has published 25 titles, including 1 book (edited), 24 articles in peer reviewed platform including journal articles, scholarly magazines, newsletters and technical notes. And has authored 10 papers/posters and oral presentations in major international professional meetings. Odilia has reviewed numerous manuscripts fo...
Format:PaperbackDimensions:324 pages, 8.75 × 6.35 × 0.68 inPublished:February 12, 2016Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0128022205

ISBN - 13:9780128022207

Look for similar items by category:

Customer Reviews of Social Aspects Of Drug Discovery, Development And Commercialization

Reviews

Extra Content

Table of Contents

SECTION I: PHARMACEUTICAL INDUSTRY, SOCIETY, AND GOVERNANCE 1. Pharmaceutical Regulation: The Role of Government 2. Trends in Innovation and the Business of Drug Discovery 3. Cash Flow Valley of Death: A Pitfall in Drug Discovery

SECTION II: THE DRUG DISCOVERY CYCLE I: DISCOVERY AND PRECLINICAL DRUG DEVELOPMENT 4. Prediscovery Research: Challenges and Opportunities 5. The Significance of Discovery Screening and Structure Optimization Studies 6. Preclinical In Vitro Studies Development and Applicability 7. Animal Utilization in Drug Development Clinical, Legal, and Ethical Dimensions 8. Pharmaceutical Formulation and Manufacturing Development: Strategies and Issues

SECTION III: THE DRUG DISCOVERY CYCLE II: CLINICAL DEVELOPMENT 9. Clinical Development: Ethics and Realities 10. Pharmacogenomics in Drug Discovery, Prospects and Clinical Applicability

SECTION IV: THE DRUG DISCOVERY CYCLE III: AUTHORIZATION AND MARKETING 11. Patents, Exclusivities, and Evergreening Strategies 12. Drug Pricing and Control for Pharmaceutical Drugs Index